Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial (vol 22, pg 494, 2023)

被引：0
|
作者：
Granit, V
Benatar, M.
Kurtoglu, M.
机构：
来源：
LANCET NEUROLOGY | 2023年 / 22卷 / 09期
关键词：
D O I：
10.1016/S1474-4422(23)00282-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E10 / E10
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
    Murphy, Claire-Louise
    Murphy, Eithne
    Duffy, Trevor
    O'Sullivan, Miriam
    Barry, Maurice
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (06) : E13 - E13
  • [32] Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial
    Low, Phillip A.
    Robertson, David
    Gilman, Sid
    Kaufmann, Horacio
    Singer, Wolfgang
    Biaggioni, Italo
    Freeman, Roy
    Perlman, Susan
    Hauser, Robert A.
    Cheshire, William
    Lessig, Stephanie
    Vernino, Steven
    Mandrekar, Jay
    Dupont, William D.
    Chelimsky, Thomas
    Galpern, Wendy R.
    LANCET NEUROLOGY, 2014, 13 (03): : 268 - 275
  • [33] Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
    Ramanan, Athimalaipet, V
    Quartier, Pierre
    Okamoto, Nami
    Foeldvari, Ivan
    Spindler, Alberto
    Fingerhutova, Sarka
    Anton, Jordi
    Wang, Zhongkai
    Meszaros, Gabriella
    Araujo, Joana
    Liao, Ran
    Keller, Stuart
    LANCET, 2023, 402 (10401): : 555 - 570
  • [34] Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
    Gouni-Berthold, Ioanna
    Alexander, Veronica J.
    Yang, Qingqing
    Hurh, Eunju
    Steinhagen-Thiessen, Elisabeth
    Moriarty, Patrick M.
    Hughes, Stephen G.
    Gaudet, Daniel
    Hegele, Robert A.
    O'Dea, Louis St L.
    Stroes, Erik S. G.
    Tsimikas, Sotirios
    Witztum, Joseph L.
    LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (05): : 264 - 275
  • [35] Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial
    Chitnis, Tanuja
    Banwell, Brenda
    Kappos, Ludwig
    Arnold, Douglas L.
    Guecueyener, Kivilcim
    Deiva, Kumaran
    Skripchenko, Natalia
    Cui, Li-Ying
    Saubadu, Stephane
    Hu, Wenruo
    Benamor, Myriam
    Le-Halpere, Annaig
    Truffinet, Philippe
    Tardieu, Marc
    LANCET NEUROLOGY, 2021, 20 (12): : 1001 - 1011
  • [36] Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
    Croop, Robert
    Goadsby, Peter J.
    Stock, David A.
    Conway, Charles M.
    Forshaw, Micaela
    Stock, Elyse G.
    Coric, Vladimir
    Lipton, Richard B.
    LANCET, 2019, 394 (10200): : 737 - 745
  • [37] Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial (vol 397, pg 2070, 2021)
    Rovin, B. H.
    Teng, Y. K. O.
    Ginzler, E. M.
    LANCET, 2021, 397 (10289): : 2048 - 2048
  • [38] Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo- controlled trial (vol22, pg 476, 2023)
    Yu, S.
    Kim, B-K
    Guo, A.
    LANCET NEUROLOGY, 2023, 22 (10): : E11 - E11
  • [39] BELIMUMAB FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS: A PHASE 2/3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Denton, C. P.
    Spiera, R.
    Jorg, D.
    Khanna, D.
    Kreuter, M.
    Kuwana, M.
    Volkmann, E.
    Cotic, J.
    Raji, O.
    Hammer, A.
    Zeccin, C.
    Van Maurik, A.
    Olaiz, J. M.
    Fahy, W.
    Tomlinson, R.
    Dastros-Pitei, D.
    Nihtyanova, S.
    Irving, E.
    Maher, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1668 - 1668
  • [40] Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial
    Burns, Alistair
    Bemabei, Roberto
    Bullock, Roger
    Cruz Jentoft, Alfonso J.
    Froelich, Lutz
    Hock, Christoph
    Raivio, Minna
    Triou, Eric
    Vandewoude, Maurits
    Wima, Anders
    Came, Elizabeth
    Van Baelen, Bart
    Hammond, Gerry L.
    van Gene, Joop C.
    Schwalen, Susanne
    LANCET NEUROLOGY, 2009, 8 (01): : 39 - 47
12345